Aprea Therapeutics, Inc. Common stock Share Price
NASDAQ: APREHealthcare
Live Aprea Therapeutics, Inc. Common stock Share Price Chart
O H L
Aprea Therapeutics, Inc. Common stock Performance Overview
Days Range
▼
$0.75Low
$0.75High
Markets Today
| Previous Close | $0.75 |
|---|---|
| Open | $0.75 |
| Volume | 117,507 |
| Day's Range | $0.75 - $0.75 |
| 52W Range | $0.55 - $1.69 |
| Market Cap | $9.20 M |
Historical Performance
| 1M Returns | +11.61 |
|---|---|
| 3M Returns | +4.90 |
| 6M Returns | +2.59 |
| 1Y Returns | -50.00 |
| 5Y Returns | -99.26 |
| 10Y Returns | NA |
Aprea Therapeutics, Inc. Common stock Fundamentals
| Market Cap | $9.20 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $285.76 K |
| ROE TTM | -0.79 |
| EPS TTM | $-1.07 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.24 |
| EBITDA | $-13.21 M |
| Profit Margin | -4409.16 |
| Market Cap | $9.20 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $285.76 K |
| ROE TTM | -0.79 |
| EPS TTM | $-1.07 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.24 |
| EBITDA | $-13.21 M |
| Profit Margin | -4409.16 |
Aprea Therapeutics, Inc. Common stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $162.46 K | $118.11 K | $1.85 K | $3.34 K | $0 | $0 |
| Gross Profit + | $162.46 K | $118.11 K | $1.85 K | $3.34 K | $0 | $0 |
| Operating Income | -$4.09 M | -$3.39 M | -$3.12 M | -$2.64 M | -$3.43 M | -$4.03 M |
| EBITDA | -$4.08 M | -$3.38 M | -$3.11 M | -$2.64 M | -$3.42 M | -$4.03 M |
| Interest Expense | $204.73 K | $178.03 K | $0 | $0 | $134.78 K | $358.92 K |
| Depreciation | $5.43 K | $5.43 K | $5.43 K | $5.43 K | $5.43 K | $5.75 K |
| Income Before Tax | -$3.93 M | -$3.24 M | -$2.97 M | -$2.46 M | -$3.29 M | -$3.59 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$3.93 M | -$3.24 M | -$2.97 M | -$2.46 M | -$3.29 M | -$3.59 M |
| Net Profit Margin | -2420.65% | -2742.23% | -160844.7% | -73587.95% | - | - |
Aprea Therapeutics, Inc. Common stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $5.51 K | $5.75 K | $5.98 K | $8.19 K | $11.98 K | $12.39 K |
| Reserve & Surplus | -$335.60 M | -$338.84 M | -$341.82 M | -$344.28 M | -$347.56 M | -$351.14 M |
| Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Liabilities | $3.36 M | $3.17 M | $2.68 M | $2.76 M | $5.30 M | $3.09 M |
| Total Liabilities | $3.36 M | $3.17 M | $2.68 M | $2.76 M | $5.30 M | $3.09 M |
| Fixed Assets | $76.09 K | $70.67 K | $65.24 K | $59.81 K | $54.38 K | $64.03 K |
| Current Assets | $19.83 M | $16.93 M | $13.94 M | $15.56 M | $47.25 M | $41.91 M |
| Total Assets | $20.22 M | $17.31 M | $14.32 M | $15.93 M | $47.61 M | $42.29 M |
Aprea Therapeutics, Inc. Common stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$3.93 M | -$3.24 M | -$2.97 M | -$2.46 M | -$3.29 M | -$3.59 M |
| Operating Cash Flow | -$3.63 M | -$3.13 M | -$3.17 M | -$2.96 M | -$2.76 M | -$3.28 M |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 | -$15.40 K |
| Financing Cash Flow | $55.85 K | $384.88 K | $357.94 K | $3.84 M | $34.62 M | -$1.94 M |
| Change in Cash | -$3.58 M | -$2.74 M | -$2.81 M | $880.28 K | $31.87 M | -$5.23 M |
Aprea Therapeutics, Inc. Common stock Return Calculator
The Aprea Therapeutics, Inc. Common stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$73
Invested Amount$10,000
Est. Returns$-9,927
About Aprea Therapeutics, Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers. It develops small molecule inhibitors designed to exploit genetic mutations in cancer to widen the therapeutic window and is intended to make treatments more effective at destroying cancer cells while sparing healthy tissue. The company's pipeline of clinical and preclinical programs includes APR-1051, a WEE1 inhibitor; ATRN-119 (Mosipasertib), an oral small molecule inhibitor of ataxia telangiectasia and Rad3-related, or ATR; and an early-stage program, APR-1602. These candidates are being developed for broad applications in cancer treatment.
Popular Stocks
FAQs
What is the share price of Aprea Therapeutics, Inc. Common stock today?
Aprea Therapeutics, Inc. Common stock (APRE) share price as of September 18, 2026 is $0.74. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Aprea Therapeutics, Inc. Common stock?
Yes, Indian Investors can invest in the Aprea Therapeutics, Inc. Common stock (APRE) Share by opening an international trading account with Angel One.
How can I purchase Aprea Therapeutics, Inc. Common stock shares in India?
Purchasing Aprea Therapeutics, Inc. Common stock (APRE) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Aprea Therapeutics, Inc. Common stock (APRE) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Aprea Therapeutics, Inc. Common stock?
Yes, you can purchase fractional shares of Aprea Therapeutics, Inc. Common stock (APRE) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Aprea Therapeutics, Inc. Common stock?
The market capitalization of Aprea Therapeutics, Inc. Common stock on September 18, 2026, is $9.20 M.
In which sector Aprea Therapeutics, Inc. Common stock belongs?
Aprea Therapeutics, Inc. Common stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Aprea Therapeutics, Inc. Common stock stocks?
In order to invest in Aprea Therapeutics, Inc. Common stock (APRE) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
